GHSI - מכפיל P/S Guardion Health Sciences, Inc.

Geopolitical tensions and inflation are driving up component logistics costs, which may constrain demand due to rising prices. Scaling nutraceutical sales is yielding a moderate effect, while new formulas are still in the pipeline. The P/S ratio history demonstrates valuation dynamics, where the value 0.40 captures this metric. Stable demand for ophthalmologic nutrition provides Guardion Health Science (GHSI) with high resilience to economic cycles.

The P/S ratio reflects the market value of a business relative to its revenue, allowing for a link between current quotes and actual cash flow to assess the extent of overpayment for an asset. By analyzing the normalized P/S of the company, an investor determines the fairness of the valuation of Guardion Health Science (GHSI), relying on the monetization of its patented formulas and the stable production of specialized nutraceuticals in US centers.